New Perspectives of Interferon-alpha2 and Inflammation in Treating Philadelphia-negative Chronic Myeloproliferative Neoplasms

被引：20
作者：
Hasselbalch, Hans C. [1 ]
Silver, Richard T. [2 ]
机构：
[1] Zealand Univ Hosp, Dept Hematol, Roskilde, Denmark
[2] Weill Cornell Med, Div Hematol & Med Oncol, Myeloproliferat Neoplasms Ctr, New York, NY USA
来源：
HEMASPHERE | 2021年 / 5卷 / 12期
关键词：
MINIMAL RESIDUAL DISEASE; CALR EXON-9 MUTATIONS; LONG-TERM TREATMENT; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; MOLECULAR RESPONSES; COMBINATION THERAPY; T-CELLS; ROPEGINTERFERON ALPHA-2B; GROWTH-FACTOR;
D O I：
10.1097/HS9.0000000000000645
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：7
相关论文
共 117 条
  • [1] Interferon-alpha for treating polycythemia vera yields improved myelofibrosis-free and overall survival
    Abu-Zeinah, Ghaith
    Krichevsky, Spencer
    Cruz, Tatiana
    Hoberman, Gabriela
    Jaber, Diana
    Savage, Niamh
    Sosner, Claudia
    Ritchie, Ellen K.
    Scandura, Joseph M.
    Silver, Richard T.
    [J]. LEUKEMIA, 2021, 35 (09) : 2592 - 2601
  • [2] Distinct effects of ruxolitinib and interferon-alpha on murine JAK2V617F myeloproliferative neoplasm hematopoietic stem cell populations
    Austin, Rebecca J.
    Straube, Jasmin
    Bruedigam, Claudia
    Pali, Gabor
    Jacquelin, Sebastien
    Vu, Therese
    Green, Joanne
    Graesel, Julius
    Lansink, Lianne
    Cooper, Leanne
    Lee, Shin-Jye
    Chen, Nien-Tsu
    Lee, Chung-Wei
    Haque, Ashraful
    Heidel, Florian H.
    D'Andrea, Richard
    Hill, Geoff R.
    Mullally, Ann
    Milsom, Michael D.
    Bywater, Megan
    Lane, Steven W.
    [J]. LEUKEMIA, 2020, 34 (04) : 1075 - 1089
  • [3] Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial
    Barbui, Tiziano
    Vannucchi, Alessandro Maria
    De Stefano, Valerio
    Masciulli, Arianna
    Carobbio, Alessandra
    Ferrari, Alberto
    Ghirardi, Arianna
    Rossi, Elena
    Ciceri, Fabio
    Bonifacio, Massimiliano
    Iurlo, Alessandra
    Palandri, Francesca
    Benevolo, Giulia
    Pane, Fabrizio
    Ricco, Alessandra
    Carli, Giuseppe
    Caramella, Marianna
    Rapezzi, Davide
    Musolino, Caterina
    Siragusa, Sergio
    Rumi, Elisa
    Patriarca, Andrea
    Cascavilla, Nicola
    Mora, Barbara
    Cacciola, Emma
    Mannarelli, Carmela
    Loscocco, Giuseppe Gaetano
    Guglielmelli, Paola
    Betti, Silvia
    Lunghi, Francesca
    Scaffidi, Luigi
    Bucelli, Cristina
    Vianelli, Nicola
    Bellini, Marta
    Finazzi, Maria Chiara
    Tognoni, Gianni
    Rambaldi, Alessandro
    [J]. LANCET HAEMATOLOGY, 2021, 8 (03): : E175 - E184
  • [4] Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms
    Baumeister, Julian
    Chatain, Nicolas
    Hubrich, Annika
    Maie, Tiago
    Costa, Ivan G.
    Denecke, Bernd
    Han, Lijuan
    Kuestermann, Caroline
    Sontag, Stephanie
    Sere, Kristin
    Strathmann, Klaus
    Zenke, Martin
    Schuppert, Andreas
    Bruemmendorf, Tim H.
    Kranc, Kamil R.
    Koschmieder, Steffen
    Gezer, Deniz
    [J]. LEUKEMIA, 2020, 34 (04) : 1062 - 1074
  • [5] Interferon Therapy in Myelofibrosis: Systematic Review and Meta-analysis
    Bewersdorf, Jan Philipp
    Giri, Smith
    Wang, Rong
    Podoltsev, Nikolai
    Williams, Robert T.
    Rampal, Raajit K.
    Tallman, Martin S.
    Zeidan, Amer M.
    Stahl, Maximilian
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (10) : E712 - E723
  • [6] Interferon alpha therapy in essential thrombocythemia and polycythemia vera-a systematic review and meta-analysis
    Bewersdorf, Jan Philipp
    Giri, Smith
    Wang, Rong
    Podoltsev, Nikolai
    Williams, Robert T.
    Tallman, Martin S.
    Rampal, Raajit K.
    Zeidan, Amer M.
    Stahl, Maximilian
    [J]. LEUKEMIA, 2021, 35 (06) : 1643 - 1660
  • [7] Bjorn M E, 2014, Leuk Res Rep, V3, P73, DOI 10.1016/j.lrr.2014.05.003
  • [8] Minimal residual disease or cure in MPNs? Rationales and perspectives on combination therapy with interferon-alpha2 and ruxolitinib
    Bjorn, Mads Emil
    Hasselbalch, Hans Carl
    [J]. EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (05) : 393 - 404
  • [9] The Role of Reactive Oxygen Species in Myelofibrosis and Related Neoplasms
    Bjorn, Mads Emil
    Hasselbalch, Hans Carl
    [J]. MEDIATORS OF INFLAMMATION, 2015, 2015
  • [10] Immunotherapy in Myeloproliferative Diseases
    Braun, Lukas M.
    Zeiser, Robert
    [J]. CELLS, 2020, 9 (06)
12345678910